MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 100 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,373,000 | +1632.1% | 934,155 | +1369.8% | 0.00% | – |
| Q4 2019 | $137,000 | -84.9% | 63,557 | -79.9% | 0.00% | -100.0% |
| Q4 2018 | $906,000 | -49.4% | 315,842 | +76.4% | 0.00% | -50.0% |
| Q3 2018 | $1,790,000 | +61.4% | 179,012 | +14.1% | 0.00% | +100.0% |
| Q2 2018 | $1,109,000 | -49.9% | 156,930 | -72.9% | 0.00% | -66.7% |
| Q1 2018 | $2,212,000 | -70.4% | 579,139 | -36.7% | 0.00% | -70.0% |
| Q4 2017 | $7,471,000 | +46.6% | 915,620 | +5.5% | 0.01% | +25.0% |
| Q3 2017 | $5,095,000 | +4254.7% | 867,927 | +4705.3% | 0.01% | – |
| Q3 2014 | $117,000 | – | 18,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
| Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
| Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
| Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
| ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
| Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
| Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
| Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
| Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |